Showing results (231-240 of 391) with videos related to
Sort By:
Pageof 40
Journal of the National Cancer Institute|June 20, 1990
Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracilM A Moore, R L Stolfi, D S MartinCancer Treatment Reports|January 1, 1981
Modulation of 5-FU action by thymidine in murine and human tumorsC W Young, T M Woodcock, D S MartinJournal of the National Cancer Institute|June 1, 1988
Failure of high-dose leucovorin to improve therapy with the maximally tolerated dose of 5-fluorouracil: a murine study with clinical relevance?D S Martin, R L Stolfi, J R ColofioreCancer Research|January 1, 1987
Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumorsR L Stolfi, R C Sawyer, D S MartinCancer Chemotherapy and Pharmacology|January 1, 1989
Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridineD S Martin, R L Stolfi, R C SawyerCancer Research|June 1, 1986
Plasma levels of a viral protein during adjuvant treatment: reflection of murine mammary tumor status and therapeutic effectE M Ritzi, D S Martin, R L StolfiHypertension (Dallas, Tex. : 1979)|February 4, 1998
Venous tone in the developmental stages of spontaneous hypertensionD S Martin, M C Rodrigo, C W AppeltThe Journal of the American Board of Family Practice|October 1, 1990
N-acetylcysteine in the treatment of human arsenic poisoningD S Martin, S E Willis, D M ClineThe Journal of Experimental Medicine|October 30, 2009
INTERSTITIAL BRONCHOPNEUMONIA : II. PRODUCTION OF INTERSTITIAL MONONUCLEAR PNEUMONIA BY THE BORDET-GENGOU BACILLUSD H Sprunt, D S Martin, J E WilliamsCancer Research|December 1, 1988
Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor systemR C Sawyer, R L Stolfi, D S MartinPageof 40